SHASUN PHARMACEUTICALS LTD. - Joint Venture Agreement

	< Back
07 Mar 2014
On July 13, 2013, Company had announced the execution of a Letter of Intent (LOI) to form a new Joint Venture (JV Company) with SeQuent Scientific Limited (SeQuent), Shasun Pharmaceuticals Ltd has now informed BSE that the Company has signed the Joint Venture Agreement on March 07, 2014 with SeQuent. The JV Company has been formed to develop, manufacture and sell veterinary products including both API (Active Pharmaceutical Ingredients) and formulations to cater to the global market. In line with the Joint Venture Agreement, Company has also executed on March 07, 2014 a Slump Sale Agreement transferring its Vizag facility to JV Company. SeQuent and Shasun will hold 73% and 27% respectively in the JV Company.<br/><br/>JV Company is expected to be operational in the first quarter of 2014-15, subject to the customary closing conditions.
View all announcements for SHASUN PHARMACEUTICALS LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us